Clinical trials
Genital Diseases, Female trials with no applicable phase
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
84 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2008 | 1 |
| 2009 | 1 |
| 2011 | 1 |
| 2012 | 2 |
| 2014 | 3 |
| 2015 | 3 |
| 2016 | 6 |
| 2017 | 6 |
| 2018 | 9 |
| 2019 | 7 |
| 2020 | 8 |
| 2021 | 5 |
| 2022 | 8 |
| 2023 | 7 |
| 2024 | 8 |
| 2025 | 7 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 47 |
| Unknown status | 21 |
| Recruiting | 7 |
| Not yet recruiting | 4 |
| Terminated | 2 |
| Withdrawn | 2 |
| Active, not recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| The Catholic University of Korea | 4 |
| Gedea Biotech AB | 3 |
| Kangbuk Samsung Hospital | 3 |
| Seoul National University Hospital | 3 |
| Zagazig University | 3 |
| Assiut University | 2 |
| Department of Medical Services Ministry of Public Health of Thailand | 2 |
| EchoNous Inc. | 2 |
| Ewha Womans University Mokdong Hospital | 2 |
| Namik Kemal University | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Genital Diseases, Female | 84 |
| Agnosia | 4 |
| Genital Neoplasms, Female | 3 |
| Neoplasms | 3 |
| Postoperative Pain | 3 |
| Urologic Diseases | 3 |
| Uterine Neoplasms | 3 |
| Vaginal Diseases | 3 |
| Vaginitis | 3 |
| Vulvovaginitis | 3 |
Trials
Showing 26 to 50 of 84. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.